Ofbeat-OZ Tablet is a combination antibiotic formulation containing Ofloxacin 200mg and Ornidazole 500mg, designed for the effective treatment of mixed bacterial and protozoal infections. Ofloxacin, a fluoroquinolone antibiotic, exhibits broad-spectrum bactericidal activity by inhibiting bacterial DNA gyrase and topoisomerase IV, thereby preventing DNA replication and transcription. Ornidazole, a nitroimidazole derivative, targets anaerobic bacteria and protozoa by disrupting DNA synthesis, leading to cell death. This synergistic combination is particularly useful in managing infections such as gastrointestinal infections, intra-abdominal infections, genitourinary tract infections, and certain respiratory tract infections where both aerobic and anaerobic pathogens are implicated. Ofbeat-OZ Tablet is indicated for conditions like amoebiasis, giardiasis, bacterial dysentery, and mixed infections caused by susceptible organisms. The medication should be used under medical supervision, with dosage adjusted according to the severity of infection and patient-specific factors. Caution is advised in patients with a history of hypersensitivity to fluoroquinolones or nitroimidazoles, as well as in those with hepatic or renal impairment. Common side effects may include gastrointestinal disturbances, headache, dizziness, and, rarely, hypersensitivity reactions. Proper adherence to prescribed therapy ensures optimal therapeutic outcomes and minimizes the risk of resistance development.